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ABSTRACT
MIC distribution data were obtained from a variety of international sources, and pooled after selection
by a deﬁned criterion. Sixty-seven of these datasets were subjected to a range of statistical goodness-of-
ﬁt tests. The log-normal distribution was selected for subsequent modelling. Cumulative counts of MIC
distribution data were ﬁtted to the cumulative log-normal distribution using non-linear least squares
regression for a range of data subsets from each antibiotic–bacterium combination. Estimated
parameters in the regression were the number of isolates in the subset, and (the log2 values of) the
mean and standard deviation. Optimum ﬁts for the cumulative log-normal curve were then used to
determine the wild-type MIC range, determined by calculating the MICs associated with the lower and
upper 0.1% of the distribution, rounding to the nearest two-fold dilution, and calculating the
probabilities of values higher and lower than these values. When plotted logarithmically, histograms of
MIC frequencies appeared normal (Gaussian), but standard goodness-of-ﬁt tests showed that the two-
fold dilution grouping of MICs ﬁts poorly to a log-normal distribution, whereas non-linear regression
gave good ﬁts to population (histogram) log-normal distributions of log2 MIC frequencies, and even
better ﬁts to log-normal cumulative distributions. Optimum ﬁts were found when the difference
between the estimated and true number of isolates in the ﬁtted subset was minimal. Sixteen antibiotic–
bacterium datasets were ﬁtted using this technique, and the log2 values of the means and standard
deviations were used to determine the 0.1% and 99.9% wild-type cut-off values. When rounded to the
nearest two-fold dilution, ‡ 98.5% of MIC values fall within the cut-off value range. Non-linear
regression ﬁtting to a cumulative log-normal distribution is a novel and effective method for modelling
MIC distributions and quantifying wild-type MIC ranges.
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INTRODUCTION
When analysing the antimicrobial susceptibility of
bacterial populations by MIC methods, it is
conventional to tabulate the numbers of isolates
at speciﬁc MIC values of a two-fold dilution
series. These data are then used to calculate MIC50
and MIC90 values, which represent the MIC
values at which 50% and 90% of the isolates are
inhibited, respectively. However, MIC50 and
MIC90 values provide only a limited insight into
which isolates might represent the wild-type
population and which isolates harbour acquired
resistance mechanisms that increase the MIC in a
given population.
The conventional method for determining
MICs that might deﬁne where wild-type MICs
end and in-vitro resistant isolates begin is visual
inspection of histograms of the MICs for single
species. This method gives reasonable approxi-
mations for many species when there is a clear-cut
bimodal distribution, but works poorly when
there is signiﬁcant overlap of wild-type and
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‘resistant’ MICs. Furthermore, the process is
observer-dependent, lacks reproducibility, and
cannot generate probabilities for particular MIC
cut-off values. However, it has been shown that
statistical techniques can be applied effectively to
zone diameter susceptibility test results [1].
Interest in describing MIC distributions in a
quantitative manner emerged during the process
of European harmonisation of breakpoints [2,3]. It
was agreed that there was a need to deﬁne wild-
type MICs and set values (epidemiological cut-off
values) that would discriminate wild-type strains
from strains with acquired resistance mecha-
nisms. These cut-off values would serve as a
foundation for the laboratory detection of ac-
quired resistance (decreased susceptibility) and
monitoring resistance development. Furthermore,
the European process for determining MIC break-
points includes a step where tentative breakpoints
are checked against deﬁned wild-type MIC dis-
tributions to ensure that breakpoints do not
divide MIC distributions of target microorgan-
isms [2,3].
Until now, there has been no mathematical ⁄
statistical description of MIC distributions. This is
somewhat surprising, given that histograms of
isolates of single species with different MICs on a
two-fold scale tend to look Gaussian (normal). The
present study examined the nature of the unimodal
statistical distributions of MICs for a range of
antibiotic–bacterium combinations, and a method
for estimating the wild-type cut-off values was
developed, based on the choice among the ﬁtted
distributions, the log-normal distribution.
MATERIALS AND METHODS
Deﬁnitions
Datasets, individual sets of data from a single laboratory; pooled
datasets, sets of data obtained by pooling individual datasets;
subsets, subsets of data extracted from pooled datasets; log-
normal distribution, a frequency (probability) distribution
where the data are distributed in a Gaussian (normal) manner
after the data points have been converted to logarithms;
skewness, lack of symmetry in a frequency distribution; kurtosis,
excessive peaking or ﬂattening of a frequency distribution
when compared with the normal distribution.
MIC data
MIC distribution data were collected from many investigators
worldwide. Most of the data were generated during monitor-
ing and surveillance programmes using standardised meth-
ods, such as those recommended by the CLSI (NCCLS) [4] and
the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) [5]. All data were collected in the form of
numbers of isolates with different MIC values on the power of
2 scale (i.e., 0.002…1, 2, 4 … 512). Datasets that were truncated
because of dilution ranges that did not appear to reach the
lower or upper ends of at least one log-normal curve were
excluded. Datasets from different studies were then pooled for
the setting of wild-type cut-off values. Only datasets with a
modal MIC that was the same, or within one two-fold dilution,
of the commonest modal value were included in the pooled
dataset.
Goodness-of-ﬁt studies
Tests for goodness-of-ﬁt to a log-normal population distribu-
tion were conducted on the log2-transformed MIC distribu-
tions of 67 different antibiotic–bacterium combinations (16
antibiotics and seven common bacterial species), with strain
numbers ranging from 24 to 49 212. Tests employed included
the chi-square test [6], the Shapiro–Wilk test [7] and the
Jarque–Bera test [8]. These tests are designed to show how
closely a frequency distribution resembles the normal Gaus-
sian distribution. Skewness and kurtosis were calculated using
moments and K-statistics [6,9]. The Kolmogorov–Smirnov one-
sample test was used to test the normality of skewness and
kurtosis values [9].
Non-linear regression studies
Non-linear least squares regression was initially used to ﬁt
some distributions of log2-transformed MIC data to a range of
symmetrical ‘bell-shaped’ theoretical population distributions.
This technique was also applied to theoretical cumulative
distributions of the same data. Regression was conducted in
Systat software v.10.2 (Systat, Richmond, CA, USA). Non-
linear least squares regression was then employed to ﬁt
cumulative log2-transformed MIC distributions to the normal
cumulative function (ZCF). Three parameters were estimated,
the mean and standard deviation (both log2), and the total
number (N) in the presumed unimodal distribution. N was
estimated rather than taken as a constant in the regression,
because of the desire to ﬁt the data to the distribution without
assuming that N truly contained only wild-type isolates.
In order to ﬁnd the best ﬁt for the unimodal population,
multiple subsets of the raw pooled cumulative distribution
data were subjected to regression, starting with the subset that
included MIC values that were either at or one dilution higher
than the (ﬁrst) mode. The procedure is demonstrated graph-
ically in Fig. 1, although shown as the frequency distribution
rather than the cumulative distribution for greater visual
clarity. Regressions were repeated with each succeeding
subset, including data from the next highest concentration,
until the estimated value of N that most closely approximated
the true N in the subset was found, i.e., the difference was a
minimum. Most often, this involved performing regression
past the point where the estimated N most closely approxi-
mated the true N, to ensure that the difference between the
values was indeed the true minimum. In a small number of
cases, the difference was a minimum when all the data were
included in the regression. An example of this technique is
shown in Table 1 and illustrated in Fig. 1.
In order to determine howmany separate MIC distributions
might be required to get an accurate estimate of the mean and
standard deviation, the same curve-ﬁtting technique was
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applied to one antibiotic–bacterium combination, Streptococcus
pneumoniae and ciproﬂoxacin, where there was a large number
(n = 38) of individual MIC distributions. The curve-ﬁttings
were conducted on successively larger pools by adding each
distribution, in turn, to the pool in random order.
Wild-type cut-off values
Wild-type cut-off values (synonymous with epidemiological
cut-off values; i.e., the MIC value which best describes where
the wild-type distribution ends [2]) were calculated from the
log2 estimates of the mean and standard deviation generated
by non-linear regression curve-ﬁtting of pooled cumulative
datasets. As most pooled datasets had total numbers > 1000,
cut-offs were selected initially at 0.1% (lower tail) and 99.9%
(upper tail) (i.e., 99.8% CI). These percentages were calculated
in Microsoft Excel v.2002 employing the NORMINV function,
which uses the estimated mean and standard deviation plus
the target percentages to calculate the MIC value deﬁning the
lower and upper tails. These MICs were then rounded up or
down to the nearest two-fold dilution, and the probabilities
associated with these concentrations were calculated from the
rounded MIC values using Excel’s NORMDIST function, the
estimated mean and standard deviation, and with the ‘Cumu-
lative’ option set to TRUE. Percentages for cut-offs were
preferred over multiples of standard deviations, as they give
easy-to-understand values and automatically assign probabil-
ities. In summary, the lower and upper wild-type cut-off
values were set to standard two-fold dilution concentrations,
and the percentages of isolates above and below those
concentrations were calculated.
RESULTS
Goodness-of-ﬁt tests
Unimodal MIC distributions ﬁt rather poorly to
the log-normal population distribution with
standard goodness-of-ﬁt tests. Of the 67
antibiotic–bacterium combinations, 13 were not
signiﬁcantly different from (log) normal by the
chi-square test, and only seven by the Jarque–Bera
test. The total numbers in these distributions in
these cases were quite low (25–234). None of the
distributions with numbers > 250 were log-
normally distributed with these two tests, and
all 67 distributions differed signiﬁcantly from the
log-normal by the Shapiro–Wilk test.
The poor ﬁts on conventional goodness-of-ﬁt
tests were attributed to the relatively coarse
grouping of MIC data. Two small datasets were
available where the MICs had been determined
using conventional two-fold dilutions and inter-
polated concentrations at the geometric midpoint
between the two-fold dilutions, e.g., 0.5, 0.707, 1,
1.414, 2 and 2.828 mg ⁄L. Fits were better (i.e.,
p values were larger) when the full dilution series,
including the interpolated values, was compared
to the conventional two-fold series (data not
shown). Skewness values ranged between ) 1.15
and + 1.34 (mean 0.09; 95% CI, ) 1.31, + 1.47) and
were distributed normally around zero (p 0.751).
Kurtosis values varied from 2.19 to 7.54 (mean
3.72; 95% CI 1.39, 6.04). The mean value was
higher than the value of 3 expected in a (log)
normal distribution. Kurtosis values were also
distributed approximately normally (p 0.134).
Fits were better when non-linear regression
was used to ﬁt distributions. This was not
unexpected, given the shape of the log2 MIC pop-
ulation distributions. These ﬁts were improved
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Fig. 1. Interative procedure for analysing increasing sub-
sets of pooled data: benzylpenicillin and Streptococcus
pneumoniae showing a visual demonstration of analysing
increasing subsets of pooled data; results of the analyses
are presented in Table 1. Data are presented as a frequency
distribution, although analyses were performed on cumu-
lative frequency distributions, as illustrated in the more
detailed examples in Fig. S1 (see Supplementary material).
The procedure involved ﬁtting the initial subset and
generating estimates for the number of strains in the
subset, the mean and the standard deviation (in log). This
procedure was repeated by adding to the previous subset
each successive column to create the next subset, and
repeating the curve-ﬁtting until it was clear that there was
a subset where the absolute difference between the
estimated and true number of strains was a minimum. In
this example, the ﬁve subsets examined showed that the
subset ‘MIC = 0.03 mg ⁄L’ gave the minimum difference.
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further when cumulative log2 MIC data were
used. Excellent ﬁts were obtained with the normal
cumulative and the logistic cumulative. Fitting
the cumulative distribution had the advantage of
directly estimating the log2 values of the mean
MIC and standard deviation. Fitting population
distributions of log2 MICs required adjustment to
the geometrical midpoint of the concentration to
yield the same results. This was expected, as the
MIC value actually represents a grouping of all
MICs, ranging from just above the lower concen-
tration to the concentration itself, and is therefore
cumulative within that concentration. Distribu-
tion ﬁts were not as good if alternative symmet-
rical ‘bell-shaped’ theoretical distributions were
used. These included the Cauchy, the Double
Exponential (Laplace) and the Lorentzian distri-
butions.
Non-linear regression studies
As the normal (Gaussian) distribution is that
accepted most widely, non-linear regression
curve ﬁtting of cumulative log2 MIC data was
selected as the preferred method for determining
means and standard deviations of MIC
distributions. Initial studies were conducted with
ﬁve antibiotic–bacterium combinations. These
studies were undertaken to determine how good
the ﬁtting and estimates were for datasets where
there were likely to be almost no resistant
isolates (Staphylococcus aureus and linezolid), a
Table 1. Optimum non-linear least squares regression ﬁtting of pooled MICs (mg ⁄L)
A. For benzylpenicillin and Streptococcus pneumoniaea
Distribution MICs
0.002 0.004 0.008 0.016 0.03 0.06 0.125 0.25 0.5 1 2 4 8
Counts 20 166 2267 9610 4698 1590 870 976 806 793 2471 1970 166
Cumulative counts 20 186 2453 12 063 16 761 18 351 19 221 20 197 21 003 21 796 24 267 26 237 26 403
Subset ﬁtted
Number of isolates Mean MIC (log2) Standard deviation (log2)
True Est. Diff. ASE Est. ⁄ ASE 95% CIb Est. ASE Est. ⁄ ASE 95% CIb Est. ASE Est. ⁄ ASE 95% Cb
£ 0.016 12 063 34 623 22 560 4413.4 7.8 ) 21 456, 90 701 ) 5.669 0.129 ) 44.1 ) 7.302, ) 4.036 0.915 0.045 20.3 0.342, 1.489
£ 0.03c 16 761 17 028 267 106.6 159.7 16 569, 17 487 ) 6.341 0.010 ) 620.6 ) 6.385, ) 6.297 0.622 0.012 53.0 0.572, 0.673
£ 0.06 18 351 17 896 ) 455 388.8 46.0 16 658, 19 132 ) 6.285 0.048 ) 130.3 ) 6.438, ) 6.131 0.628 0.063 10.9 0.482, 0.882
£ 0.125 19 221 18 498 ) 723 424.6 43.6 17 319, 19 677 ) 6.241 0.063 ) 98.5 ) 6.417, ) 6.065 0.740 0.086 8.6 0.501, 0.980
£ 0.25 20 197 19 089 ) 1108 480.6 39.7 17 853, 20 324 ) 6.192 0.083 ) 74.8 ) 6.405, ) 5.597 0.810 0.114 7.1 0.517, 1.103
B. For ciproﬂoxacin and Streptococcus pneumoniaed
Distribution MICs
0.008 0.016 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512
Counts 8 13 26 31 104 1529 9838 36 717 13 468 1065 242 65 99 73 6 3 228
Cumulative counts 8 21 47 78 182 1711 11 549 48 266 61 734 62 799 63 041 63 106 63 205 63 278 63 284 63 287 63 515
Subset ﬁtted
Number of isolates Mean MIC (log2) Standard deviation (log2)
True Est. Diff. ASE Est. ⁄ ASE 95% CIb Est. ASE Est. ⁄ ASE 95% Cb Est. ASE Est. ⁄ ASE 95% Cb
£ 2 61 734 62 305 571 640.5 97.3 60 737, 63 872 ) 0.459 0.018 ) 25.8 ) 0.502, ) 0.415 0.612 0.019 32.0 0.565, 0.658
£ 4c 62 799 62 587 ) 211 403.1 155.3 61 634, 63 541 ) 0.454 0.015 ) 30.7 ) 0.489, ) 0.419 0.616 0.017 36.5 0.576, 0.656
£ 8 63 041 62 753 ) 288 311.0 201.8 62 036, 63 470 ) 0.451 0.014 ) 33.1 ) 0.482, ) 0.419 0.619 0.016 38.8 0.582, 0.656
£ 16 63 106 62 848 ) 258 256.6 245.0 62 267, 63 428 ) 0.449 0.013 )35.0 ) 0.478, ) 0.420 0.620 0.015 40.9 0.586, 0.655
£ 32 63 205 92 923 ) 282 221.1 284.5 62 430, 63 416 ) 0.448 0.012 ) 36.5 ) 0.475, ) 0.420 0.622 0.015 42.5 0.589, 0.654
£ 64 63 278 62 985 ) 293 195.9 321.5 62 554, 63 416 ) 0.447 0.012 ) 37.7 ) 0.473, ) 0.421 0.623 0.014 43.8 0.591, 0.654
£ 128 63 284 63 030 ) 254 175.8 358.5 62 647, 63 413 ) 0.446 0.011 ) 39.0 ) 0.471, ) 0.421 0.624 0.014 45.2 0.593, 0.654
£ 256 63 287 63 063 ) 224 159.4 395.6 62 719, 63 408 ) 0.445 0.011 ) 40.3 ) 0.469, ) 0.421 0.624 0.013 46.7 0.595, 0.653
£ 512 63 515 63 115 ) 400 149.6 421.9 62 794, 63 436 ) 0.444 0.011 ) 40.5 ) 0.468, ) 0.421 0.625 0.013 46.9 0.596, 0.654
Est., non-linear regression estimate of value; Diff., estimate of N minus true N; ASE, asymptotic standard error; Est. ⁄ASE, estimate divided by asymptotic standard error.
aPool consisted of 17 independently generated datasets; isolates with putative resistance are included.
b95% CI of estimate of value.
cThis subset gave the smallest difference between the estimated and true number of isolates in the subset, and was therefore selected for estimates of the mean and standard
deviation for the antibiotic–bacterium concentration.
dPool consisted of 38 independently generated datasets; isolates with putative resistance are included.
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small proportion of resistant isolates (Escherichia
coli and gentamicin), and a prevalence of resist-
ant isolates (Streptococcus pneumoniae and benzyl-
penicillin; Escherichia coli and ampicillin). An
additional dataset, Strep. pneumoniae and
ciproﬂoxacin, was also included, as its presumed
wild-type distribution crosses what is widely
considered to be the resistance breakpoint. In
order to avoid making assumptions about the
position of the upper tail of the ‘susceptible’
(lower) distribution, regressions were performed
on a range of data subsets, starting with the
subset of values up to the concentration one
above the mode (or sometimes at the mode), and
repeating the regression with each dataset up to
each successive concentration until all concen-
trations were included. Table 1 shows how this
was performed for two of these antibiotic–bac-
terium pairs. These studies revealed the follow-
ing:
1. An optimum ﬁt could be found for the three
estimated parameters, N, and the log2 values of
the mean and the standard deviation. The ﬁt
was considered to be optimum when the
absolute value of the ratio of the estimate of
the parameter to the asymptotic standard error
was maximal.
2. Optimum ﬁts for each of the estimated para-
meters could occur with different subsets, and
most often the optimum ﬁts for the mean and
standard deviation were found with the same
data subset.
3. When acquired resistance is absent or uncom-
mon, the ﬁt tends to improve as more data are
included in the analysis.
4. When acquired resistance is prevalent, the ﬁt
reaches optimum values and then deteriorates.
5. While other subsets might yield optimum ﬁts
for one or more of the parameters individually,
reasonable values for mean and standard
deviation occurred when the estimate of the
number in the data subset generated by the
non-linear regression most closely approximat-
ed the true number (i.e., the difference was a
minimum). This subset gave values for the
mean and standard deviation that were
extremely close to those seen with subsets that
gave optimumﬁt for the individual parameters.
Fig. S1 (see Supplementary material) demon-
strates graphically how well the ﬁts appeared
across different data subsets for four antibiotic–
bacterium combinations, one where acquired
resistance is rare (Staph. aureus and linezolid),
one where it is common (E. coli and ampicillin),
and two data sets where resistant strains appear
to merge with susceptible wild-type strains (Strep.
pneumoniae with ciproﬂoxacin and benzylpenicil-
lin).
Analysis of successive pools of MIC distribu-
tions for Strep. pneumoniae and ciproﬂoxacin
revealed that the numbers of pools required to
closely approximate the mean and standard
deviation shown in Table 2 were 10 and 20,
respectively. However, when wild-type cut-off
values were determined as above from the differ-
ent means and standard deviations, the values
were almost always the same after only three
datasets of distributions had been pooled. This
was caused by the rounding step in determining
cut-off values.
Epidemiological cut-off values
Calculated epidemiological cut-off values were
determined for 16 antibiotic–bacterium combina-
tions, as shown in Table 2. These values agreed
with approximations of cut-off values obtained by
visual inspection.
DISCUSSION
EUCAST has recently deﬁned the term ‘wild-
type’ and its relationship to the term ‘the epide-
miological cut-off value’: i.e., a microorganism is
deﬁned as wild-type for a species by the absence
of acquired and mutational resistance mecha-
nisms to the drug in question, and a microorgan-
ism is categorised as wild-type for a species by
applying the appropriate cut-off value in a
deﬁned phenotypic test system; this cut-off value
will not be altered by changing circumstances;
wild-type microorganisms may or may
not respond clinically to antimicrobial treat-
ment (URL:http://www.eucast.org). However,
EUCAST has not described exactly how the
epidemiological cut-off value should be derived.
Deﬁning the expected range of MIC values for
wild-type strains by the method described here
has a number of advantages. First, a normal range
is provided that can be used to deﬁne (statisti-
cally) strains that are potentially abnormal. Sec-
ond, because the method is species-speciﬁc, it
allows comparison of individual antibiotics
between species, and provides an alert about
422 Clinical Microbiology and Infection, Volume 12 Number 5, May 2006
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possibly incorrect identiﬁcation when a result is
out of range, especially when it is below the lower
cut-off value. Third, it provides, for the ﬁrst time,
a quantitative mean, standard deviation and CI
for wild-type MICs that may be used for a variety
of purposes, such as Monte Carlo simulations. At
present, Monte Carlo simulations for developing
pharmacodynamic breakpoints are conducted
against unselected and non-statistically deﬁned
MIC distributions.
In this analysis, the percentages of wild-type
strains above and below the wild-type cut-off
values have been calculated in order to show the
effects of rounding to the nearest concentration in
the two-fold series. In effect, these percentages
indicate what proportions of true wild-type
strains lie above and below the cut-off values.
The percentages do not indicate the probability
that a random strain with an MIC above or below
the cut-offs is abnormal. In particular, they do not
deﬁne the probability of a strain with an MIC
above the upper cut-off value harbouring a
resistance mechanism. To calculate that probabil-
ity, it is possible to use Excel’s NORMDIST function.
For instance, for E. coli and ampicillin, the prob-
ability of a strain with an MIC of 16 mg ⁄L (more
precisely, a strain with an MIC in the range of > 8
to £ 16 mg ⁄L) being normal is 0.00296. Although
this probability looks low, in percentage terms
(0.296%) it is very close to the calculated percent-
age of wild-types above the upper cut-off value.
Thus, there is uncertainty about whether it would
be normal or abnormal, and other non-MIC
methods would be required to decide this. In
contrast, a strain with an MIC of 64 mg ⁄L has a
probability of 0.000000018 of being normal.
Clearly, this very low probability suggests that
such a strain would harbour a resistance mech-
anism.
This technique has been developed in order to
deal with a range of questions. First, is it possible
to pool MIC distributions from different sources?
It is known that individual MICs vary from assay
to assay (test variance), depending, among other
factors, on type and variation of medium, pres-
ence of supplements, incubation atmosphere, time
of incubation, test-to-test variations in precision of
dilutions and inoculum, and endpoint reading.
This variation forms the basis of quality control
MIC ranges for the quality control isolates recom-
mended in each method. Test variance accounts
for almost all of the differences among individualT
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sets of MIC distributions. The second type of
variance, strain variance, accounts for the fact that
MICs for single antibiotic–bacterium combina-
tions are true statistical distributions related to
biological variation. While there are likely to be
better methods for pooling data than that des-
cribed here (i.e., pooling datasets that have a
mode within one concentration of the commonest
mode), this approach conﬁrms the widely accep-
ted concept that a one-dilution difference between
MICs is within the error of the test. Importantly, it
also allows all the signiﬁcant features of test
variance to be included within the wild-type
normal range. It is believed that this approach has
been partly validated by the analysis of successive
pools of the Strep. pneumoniae and ciproﬂoxacin
data, showing that pooling of at least three
separate distributions will give a good approxi-
mation of the wild-type cut-offs, although the
optimum may be closer to 20 distributions.
Is there a statistical technique that models MIC
distributions? It has been found that unimodal
wild-type MIC distributions follow a log-normal
distribution closely. Standard statistical goodness-
of-ﬁt tests do not demonstrate this clearly because
of the coarse grouping created by two-fold dilu-
tions. However, there is a high level of ﬁt using
non-linear regression to the log-normal distribu-
tion. The ﬁt is excellent for the cumulative log-
normal distribution. This results from the fact that
attempting to ﬁt curves to a coarsely grouped
population distribution does so using distorted
data,whereas the cumulative counts are inﬂuenced
minimally by the coarseness of grouping, because
they are merely points on a cumulative curve.
Logarithms to the base 2 were selected for the
analysis, as these are the most familiar, giving
integer values for the typical two-fold dilution
series (… 0.5 ﬁ )1, 1 ﬁ 0, 2 ﬁ 1, 4 ﬁ 2, etc.).
Other bases can be used to equal effect. It is not
possible to apply an alternative technique devel-
oped recently for modelling zone diameter distri-
butions [1], as there are too fewvalues either side of
the mode.
Is it possible to determine which subset of data
is best for the curve ﬁt? This is a particularly
important question for MIC distributions where
resistant sub-populations are present. Instead of
ﬁtting an arbitrarily selected subset, curves were
ﬁtted to a range of subsets, and an estimate of the
number of isolates in the subset was included in
the ﬁtted equation. The optimum ﬁt was deﬁned
as the ﬁt determined when the difference between
the estimate of the number and the true number
was minimal. This ﬁt often, but not always, gave
estimates for the mean and standard deviation
associated with the smallest asymptotic standard
error. However, it always yielded the most
plausible subset, based on visual inspection of
the MIC distribution. When a signiﬁcant propor-
tion of isolates in the whole MIC distribution had
elevated MICs (i.e., were ‘resistant’), ﬁts rapidly
became poorer when larger and larger subsets
were included in the ﬁt. Thus, the technique of
selecting the ‘minimum absolute difference in N’
subset readily excluded isolates that had MICs
above the wild-type (Fig. 1).
What MIC range percentage should be used to
deﬁne the wild-type? As there were large num-
bers of isolates in the pooled datasets, a broader
range was chosen than the conventionally used
MIC90 or the statistical convention of a 95% CI.
Instead, the wild-type was deﬁned as an MIC in
the range of 0.1% and 99.9%, i.e., the 99.8%
interval. In order to avoid a wild-type range
calculated from selecting MICs that are not
normally generated in MIC tests, the MICs calcu-
lated for 0.1% and 99.9% were adjusted to the
nearest two-fold dilution, and the percentage
probabilities of isolates having lower and higher
values, respectively, were recalculated. Table 2
demonstrates that this rounding still results in a
range that includes > 98.5% of the wild-type
population.
Fitting an MIC dataset to the cumulative log-
normal distribution has general applicability. It is
not only valid for pooled data, but can also be
used on datasets generated by a single laboratory
and method. It is expected that eventually there
will be wider application of the curve-ﬁtting
technique for MIC data.
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